Spero Therapeutics

-$0.37 (-2.34%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell SPRO and other stocks, options, and ETFs commission-free!

About SPRO

Spero Therapeutics, Inc. Common Stock, also called Spero Therapeutics, is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant, or MDR, bacterial infections.

CEO
Ankit A. Mahadevia
Employees
89
Headquarters
Cambridge, Massachusetts
Founded
2013

SPRO Key Statistics

Market Cap
457.44M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
99.81K
High Today
$15.80
Low Today
$15.14
Open Price
$15.80
Volume
71.66K
52 Week High
$23.64
52 Week Low
$8.50

SPRO Earnings

-$1.32
-$0.88
-$0.44
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 5, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure